Browse/Specialty Dietary Substance
Specialty Dietary Substance

Lactobacillus Rhamnosus

01 / OVERVIEW

What this compound does

WHAT IT DOES

Lactobacillus rhamnosus is a friendly type of bacteria that lives in your gut and helps keep your digestive system healthy. When you take it as a supplement, it settles in your intestines and works like a helpful neighbor—it crowds out harmful germs, strengthens the walls of your gut so nothing leaks through, and talks to your immune system to keep it balanced. Different strains of this probiotic can also help with things like digestion, immune support, and even mood, because your gut and brain are closely connected. This supplement is often used to prevent or treat diarrhea, especially from antibiotics, and may help with conditions like irritable bowel syndrome (IBS) or eczema in children. It's generally safe for most people, but those with weakened immune systems or serious illnesses should check with a doctor first. The effects can vary depending on the specific strain and dose, and it may take a few days to a couple of weeks to notice changes.

KEY BENEFITS
Supports healthy digestion and regular bowel movements
Helps prevent or reduce antibiotic-related diarrhea
May ease symptoms of irritable bowel syndrome (IBS)
Strengthens the body's natural defenses against infections
May reduce the risk of eczema in infants and young children
Promotes a balanced gut environment
BEST FOR
  • • People taking antibiotics who want to avoid diarrhea
  • • Adults and children with mild to moderate IBS
  • • Infants at high risk for eczema or allergies
  • • Travelers looking to prevent stomach issues
  • • Anyone wanting to support overall gut health
WHAT TO EXPECT

You may notice improved digestion and fewer stomach upsets within a few days to two weeks of regular use. For antibiotic-related diarrhea, taking it from the start of antibiotics can help prevent symptoms.

WHO SHOULD AVOID THIS
  • • People with severely weakened immune systems (e.g., chemotherapy, organ transplant)
  • • Premature infants or those with short bowel syndrome
  • • Individuals with central venous catheters (risk of infection)
  • • Those with known allergies to any ingredients in the supplement
MYTHS & FACTS
Myth: All probiotic supplements are the same, so any brand will work.
Fact: Different strains of Lactobacillus rhamnosus have unique properties, and benefits are strain-specific. The dose, formulation, and viability also matter. Not all products deliver the same results.
Myth: Probiotics like L. rhamnosus can replace antibiotics for infections.
Fact: Probiotics support gut health and may help prevent some infections, but they are not a substitute for antibiotics in treating bacterial infections. They are best used as a complement, not a replacement.
Myth: You need to take probiotics forever to see any benefit.
Fact: Many benefits, such as preventing antibiotic-associated diarrhea, occur with short-term use. For ongoing conditions like IBS, longer use may help, but effects can persist for weeks after stopping as the gut microbiome adjusts.
At a glance
Typical dose
5 to 10 billion CFU daily
Loading: 10 billion CFU/day × 3-5 days for acute diarrhea or traveler's diarrhea prevention
Evidence
—
Studies indexed7
How it's made

Production details below.

03 / DOSAGE

How much, when

MAINTENANCE

5 to 10 billion CFU daily

LOADING PROTOCOL

10 billion CFU/day × 3-5 days for acute diarrhea or traveler's diarrhea prevention

Take with food to improve gastric transit survival; refrigerate live cultures for stability; avoid taking with hot beverages

TIMING

Lactobacillus Rhamnosus — Any dose

Take with food

02 / EVIDENCE

Peer-reviewed studies

  • PMID: 23873056

    Prevents antibiotic-associated diarrhea

    Meta-analysis of 12 RCTs (n=1,496) found L. rhamnosus GG reduced risk of AAD by 61% (RR 0.39, 95% CI 0.25-0.62) compared to placebo.

    A
  • PMID: 25989339

    Reduces eczema risk in infants

    Systematic review of 6 RCTs (n=2,041) showed prenatal and postnatal L. rhamnosus GG supplementation reduced eczema incidence by 22% (RR 0.78, 95% CI 0.69-0.89).

    A
  • PMID: 26712364

    Improves IBS symptoms

    RCT (n=362) with L. rhamnosus GG for 6 months found significant reduction in IBS symptom severity score (mean difference -22.3, p=0.02) vs placebo.

    B
  • PMID: 26290464

    Reduces respiratory infection duration

    Meta-analysis of 10 RCTs (n=3,451) found L. rhamnosus GG shortened duration of acute respiratory infections by 0.8 days (95% CI -1.2 to -0.4) in children.

    A
  • PMID: 25274573

    Prevents necrotizing enterocolitis

    Cochrane review of 4 RCTs (n=1,399 preterm infants) found L. rhamnosus reduced risk of NEC by 47% (RR 0.53, 95% CI 0.31-0.92).

    A
  • PMID: 29562342

    Modulates gut microbiota composition

    RCT (n=40 healthy adults) showed 4-week L. rhamnosus GG supplementation increased fecal Lactobacillus counts and butyrate levels, with no major adverse effects.

    B
  • PMID: 23968877

    May reduce vaginal infection recurrence

    Small RCT (n=55) found L. rhamnosus plus standard treatment reduced bacterial vaginosis recurrence at 3 months (18% vs 40%, p=0.04).

    C
  • PMID 25922398 · 2015Safety Study

    Risk and safety of probiotics

    B
  • PMID 35727573 · 2022RCT

    Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial

    B
  • PMID 38613116 · 2024RCT

    Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial

    B
  • PMID 36018495 · 2022Narrative Review

    Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review

    B
  • PMID 38659110 · 2024Mechanistic Study

    Dietary supplements: clinical cholesterol-lowering efficacy and potential mechanisms of action

    B
04 / INTERACTIONS

Medicine interactions

  • Immunosuppressants (e.g., cyclosporine, tacrolimus)· immunosuppressant

    Live bacteria may cause opportunistic infection in immunocompromised patients.

    → Consult physician before use; avoid in severe immunosuppression.

    HIGH

  • Antibiotics (broad-spectrum)· antibiotic

    Antibiotics may reduce viability of L. rhamnosus if taken concurrently.

    → Take probiotic at least 2-3 hours apart from antibiotic doses to minimize inactivation.

    MODERATE

  • Antifungals (e.g., fluconazole)· antifungal

    No significant interaction expected; L. rhamnosus is not affected by most antifungals.

    → No special precautions needed.

    LOW

  • Proton pump inhibitors (PPIs)· acid_reducer

    Reduced stomach acid may improve probiotic survival, but no adverse interaction.

    → No dose adjustment needed; may actually enhance colonization.

    LOW

This page is a reference summary, not a prescription. Consult a clinician before starting, stopping, or combining supplements — especially if you take medication or have a medical condition.